GH

Darya Chudova

Known title: Chief Technology OfficerCIK: 0001977179

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 17, 2026

Guardant Health Wins Patent Ruling, Morgan Stanley Lifts Target. Guardant Health secured a favorable decision from the U.S. Patent Trial and Appeal Board, which rejected a challenge to its core duplex sequencing patent. This legal win supports the company's position in the growing liquid biopsy market. Additionally, Morgan Stanley maintained an Overweight rating and raised its price target to $200, citing strong fundamentals in the diagnostics sector.

this person other insiders at GH

Transaction History

GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$755K
GH▼ Sell$1.4M
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$737K
GH▼ Sell$444K
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$639K
GH▲ Buy$0
GH▼ Sell$492K
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$1.3M
GH▲ Buy$0
GH▼ Sell$567K
GH▼ Sell$0
GH▼ Sell$0
GH▼ Sell$983K
GH▼ Sell$1.4M
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$511K
GH▲ Buy$0
GH▼ Sell$11K
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$77K
GH▲ Buy$0
GH▼ Sell$7K
GH▲ Buy$0
GH▼ Sell$179K
GH▲ Buy$0
GH▼ Sell$65K
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$129K
GH▲ Buy$0
GH▼ Sell$392K
GH▲ Buy$0
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$38K
GH▲ Buy$0
GH▼ Sell$6K
GH▲ Buy$0
GH▼ Sell$117K
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$89K
GH▼ Sell$30K
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$3K
GH▲ Buy$0
GH▼ Sell$14K
GH▼ Sell$3K
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$80K
GH▲ Buy$0
GH▼ Sell$11K
GH▲ Buy$0
GH▼ Sell$2K
GH▲ Buy$58K
GH▲ Buy$0
GH▼ Sell$15K
GH▲ Buy$0
GH▼ Sell$3K
GH▲ Buy$35K
GH▲ Buy$0
GH▼ Sell$55K
GH▲ Buy$40K
GH▲ Buy$0
GH▼ Sell$34K
GH▲ Buy$0
GH▼ Sell$4K
GH▼ Sell$19K
GH▲ Buy$0
GH▲ Buy$0
GH▼ Sell$3K

We use analytics to understand how market-wall is used. No personal data is sold.